Ind-Swift Labs to issue ₹137.2 Cr warrants to promoter group

Ind-Swift Laboratories Ltd's Board of Directors approved the preferential issue of up to 70 lakh fully convertible warrants to Essix Biosciences Limited, a promoter group entity. Each warrant is priced at ₹196, aggregating up to ₹137.20 crore. These warrants will be convertible into an equivalent number of equity shares within 18 months from allotment. The Board also authorized a committee for this issue and approved an Extra-Ordinary General Meeting (EGM) to be held on August 5, 2026, to seek shareholder approval for the proposed preferential issue and an alteration in the Article of Association.